{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "LIN",
  "name": "Linde plc",
  "url": "https://frontierpicks.com/dossiers/LIN/",
  "json_url": "https://frontierpicks.com/dossiers/LIN.json",
  "status": "WATCHLIST",
  "current_conviction": "LOW",
  "archetype": {
    "code": "a7",
    "n": 7
  },
  "current_thesis": "Linde is more likely to lag than lead the S&P 500 over three months: the shares trade at 34.5 times earnings after an 11.3% three-month rise while fourth-quarter guidance slows EPS growth to 5%–7%. The early-February 2027 report and 2027 outlook settle it.",
  "invalidation_trigger": "A daily close above $549, which would put the shares above their July 2026 52-week high and show them leading, or a 2027 adjusted EPS outlook above the 8%–9% growth guided for 2026.",
  "catalyst_date": "2026-12-01",
  "catalyst_estimated": true,
  "portfolio": null,
  "pick": null,
  "themes": [],
  "tags": [],
  "sources": [],
  "caveats": [],
  "source_links": [
    {
      "title": "LINDE PLC - Form 8-K - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0001707925/000165495426009199/lin_ex991.htm",
      "date": null
    },
    {
      "title": "Zacks",
      "url": "https://www.zacks.com/stock/news/3019656/lin-q3-earnings-call-highlights-restructuring-and-growth-outlook",
      "date": null
    },
    {
      "title": "LINDE PLC - Form 10-Q - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0001707925/000162828026068079/lin-20260930.htm",
      "date": null
    },
    {
      "title": "Linde Q2 Earnings Call Highlights",
      "url": "https://www.marketbeat.com/instant-alerts/linde-q2-earnings-call-highlights-2026-07-31/",
      "date": "2026-07-31"
    }
  ],
  "evidence": [
    {
      "claim": "Third-quarter 2026 sales were $9,404 million, up 9% from a year earlier, with underlying sales up 5%; adjusted operating margin was 29.4%.",
      "source": "Linde third-quarter 2026 earnings release, Form 8-K exhibit 99.1",
      "as_of": "2026-10-29"
    },
    {
      "claim": "Third-quarter adjusted EPS was $4.59, up 9%; reported EPS was $3.66, down 11%.",
      "source": "Linde third-quarter 2026 earnings release, Form 8-K exhibit 99.1",
      "as_of": "2026-10-29"
    },
    {
      "claim": "Full-year 2026 adjusted EPS guidance is $17.82–17.92, against $17.70–17.90 given on 2026-07-31; fourth-quarter guidance is $4.40–4.50, up 5%–7%.",
      "source": "Linde third-quarter 2026 earnings release",
      "as_of": "2026-10-29"
    },
    {
      "claim": "A $425 million charge was split roughly half to severance in lower-growth regions, with most of the rest going to portfolio and asset actions at Lincare.",
      "source": "Linde third-quarter 2026 earnings call",
      "as_of": "2026-10-29"
    },
    {
      "claim": "Gross margin fell to 47.2% in the quarter to 2026-09-30, from 49.3% in the quarter to 2025-06-30.",
      "source": "Linde 10-Q filings",
      "as_of": "2026-10-29"
    },
    {
      "claim": "Backlog stood at $66,000 million at 2026-09-30, up 6.5% from a year earlier; debt was $26,702 million.",
      "source": "Linde third-quarter 2026 10-Q",
      "as_of": "2026-09-30"
    },
    {
      "claim": "The chief financial officer exercised 228,175 options and sold 86,833 shares on the open market at an average of $521.21.",
      "source": "SEC Form 4 filed 2026-11-06",
      "as_of": "2026-11-04"
    },
    {
      "claim": "Goldman Sachs raised its Linde target to $595 from $580; BMO cut its target to $540 from $546 on 2026-11-03.",
      "source": "Goldman Sachs and BMO research notes, as reported by fiscal.ai",
      "as_of": "2026-11-03"
    }
  ],
  "view_changes": [],
  "frame": {
    "as_of": "2026-11-14",
    "business": "Linde sells industrial gases such as oxygen, nitrogen, argon and hydrogen to manufacturers, chip makers, hospitals and refiners. Most sales come under long-term on-site and bulk supply contracts. Through Linde Engineering it also builds gas plants. Revenue was $9,404 million in the quarter to 2026-09-30.",
    "change": {
      "now": "On 2026-10-29 Linde reported third-quarter sales of $9,404 million (up 9%), raised full-year adjusted EPS guidance to $17.82–17.92, and took a $425 million charge for severance and actions at Lincare.",
      "next": "Reported operating margin fell to 22.9% from 27.5% in the June quarter, and gross margin slid to 47.2%. The company plans 2026 capital spending of $5.5–6.0 billion, against $5,080 million of free cash flow over four quarters.",
      "linked": "Air Products (APD) competes for the same on-site and electronics gas projects. AdaptHealth (AHCO) faces a rival in US home oxygen, Lincare, now under strategic review."
    },
    "priced_in": "At the 2026-11-13 close (filed inputs to 2026-10-29), the shares trade at a P/E of 34.5, EV/sales of 7.3 and EV/EBIT of 28.8, with a 2.1% free-cash-flow yield. That holds only if revenue keeps growing near the 9.2% of the September quarter and the operating margin returns from 22.9% toward the 27%–28% of earlier 2026 quarters.",
    "links": {
      "customers": [],
      "suppliers": [],
      "competitors": [
        {
          "ticker": "APD",
          "url": null
        },
        {
          "ticker": "AHCO",
          "url": null
        }
      ]
    }
  },
  "filed_numbers": {
    "as_of": "2026-11-17",
    "sector": "Basic Materials",
    "financials": {
      "status": "ok",
      "reason": null,
      "close_date": "2026-11-17",
      "latest_quarter": "2026-09-30",
      "figures": {
        "revenue": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-10-29",
              "restated": null,
              "value_musd": 9404,
              "yoy_pct": 9.2
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-31",
              "restated": null,
              "value_musd": 9289,
              "yoy_pct": 9.3
            },
            {
              "end": "2026-03-31",
              "filed": "2026-05-01",
              "restated": null,
              "value_musd": 8781,
              "yoy_pct": 8.2
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-25",
              "restated": null,
              "value_musd": 8764,
              "yoy_pct": 5.8
            },
            {
              "end": "2025-09-30",
              "filed": "2025-10-31",
              "restated": null,
              "value_musd": 8615,
              "yoy_pct": 3.1
            },
            {
              "end": "2025-06-30",
              "filed": "2025-08-01",
              "restated": null,
              "value_musd": 8495,
              "yoy_pct": 2.8
            }
          ]
        },
        "gross_margin": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-10-29",
              "restated": null,
              "pct": 47.2
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-31",
              "restated": null,
              "pct": 47.7
            },
            {
              "end": "2026-03-31",
              "filed": "2026-05-01",
              "restated": null,
              "pct": 48.5
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-25",
              "restated": null,
              "pct": 48.1
            },
            {
              "end": "2025-09-30",
              "filed": "2025-10-31",
              "restated": null,
              "pct": 49.2
            },
            {
              "end": "2025-06-30",
              "filed": "2025-08-01",
              "restated": null,
              "pct": 49.3
            }
          ]
        },
        "operating_margin": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-10-29",
              "restated": null,
              "pct": 22.9
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-31",
              "restated": null,
              "pct": 27.5
            },
            {
              "end": "2026-03-31",
              "filed": "2026-05-01",
              "restated": null,
              "pct": 27.8
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-25",
              "restated": null,
              "pct": 23
            },
            {
              "end": "2025-09-30",
              "filed": "2025-10-31",
              "restated": null,
              "pct": 27.5
            },
            {
              "end": "2025-06-30",
              "filed": "2025-08-01",
              "restated": null,
              "pct": 27.7
            }
          ]
        },
        "pretax_income": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": 2128
        },
        "net_income": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "four_quarters_end": "2026-09-30",
          "value_musd": 1692,
          "four_quarters_musd": 7007
        },
        "operating_cash_flow": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "first_end": "2025-12-31",
          "value_musd": 10710
        },
        "capital_spending": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "first_end": "2025-12-31",
          "value_musd": 5630
        },
        "free_cash_flow": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "first_end": "2025-12-31",
          "value_musd": 5080
        },
        "diluted_share_change": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "base_end": "2025-09-30",
          "pct": -1.9
        },
        "cash": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": 3947
        },
        "debt": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": 26702
        },
        "net_cash": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": -22755
        },
        "deferred_revenue": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": 2447,
          "yoy_pct": -3.4
        },
        "backlog": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": 66000,
          "yoy_pct": 6.5
        },
        "receivables": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": 5595
        },
        "inventory": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": 2129
        },
        "equity": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-29",
          "value_musd": 39422
        },
        "market_value": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-09-30",
          "basis_filed": "2026-10-29",
          "value_musd": 236478.6
        },
        "enterprise_value": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-09-30",
          "basis_filed": "2026-10-29",
          "value_musd": 259233.6
        },
        "ev_sales": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-09-30",
          "basis_filed": "2026-10-29",
          "multiple": 7.2
        },
        "ev_ebit": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-09-30",
          "basis_filed": "2026-10-29",
          "multiple": 28.3
        },
        "pe": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-09-30",
          "basis_filed": "2026-10-29",
          "multiple": 33.7
        },
        "pb": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-09-30",
          "basis_filed": "2026-10-29",
          "multiple": 6
        },
        "fcf_yield": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-09-30",
          "basis_filed": "2026-10-29",
          "pct": 2.1
        }
      }
    },
    "short_interest": {
      "status": "ok",
      "settlement": "2026-10-30",
      "published": "2026-11-10",
      "short_pct_of_outstanding": 1.45,
      "days_to_cover": 3.4,
      "change_pct": 7.3
    },
    "insiders": {
      "status": "not available yet",
      "as_of": null,
      "windows": []
    }
  },
  "body_markdown": "## Current Thesis\n\nLinde is more likely to lag than lead the S&P 500 over the next three months. The shares rose 11.3% in three months to a $526.06 close on 2026-11-13, and they trade at 34.5 times earnings, while the company's own fourth-quarter guidance slows adjusted earnings-per-share (EPS) growth to 5%–7%. The fourth-quarter report and the 2027 outlook, expected in early February 2027, settle it.\n\nThe quarter itself was solid. Linde reported third-quarter sales of $9,404 million on 2026-10-29, up 9% from a year earlier. Adjusted EPS was $4.59, up 9% and above the company's own $4.45–4.55 guide. Full-year adjusted EPS guidance moved to $17.82–17.92, from $17.70–17.90 on 2026-07-31. The price already reflects that steady compounding. The next step down in growth is in the guidance.\n\nTwo items weigh on reported results. The company took a $425 million charge in the quarter. On the 2026-10-29 call, Chief Executive Sanjiv Lamba said about half went to severance in lower-growth regions and most of the rest to actions at Lincare, the US home-care business, which is now under a strategic review. Reported EPS fell 11% to $3.66. The rating is Low because valuation, slowing guidance and a five-quarter slide in gross margin leave little room for the shares to outrun the index, even though analysts raised most targets after the report.\n\n## Bull Case\n\n- **Pricing still runs ahead of costs.** In the third quarter of 2026, Americas underlying sales rose 9% on 6% higher pricing and 3% higher volumes, and Asia-Pacific rose 8% on 5% higher volumes, according to the company's 2026-10-29 release.\n- **Contracted work keeps growing.** The 10-Q filed 2026-10-29 shows a backlog of $66,000 million at 2026-09-30, up 6.5% from a year earlier, and the release cites a $7.9 billion contractual sale-of-gas project backlog.\n- **Cash funds buybacks and dividends.** Operating cash flow was $10,710 million over the four quarters to 2026-09-30 and free cash flow $5,080 million (10-Q). The diluted share count fell 1.9% from a year earlier, and the company returned $1,685 million to shareholders in the third quarter.\n- **Analysts lifted targets after the report.** Goldman Sachs raised its target to $595 on 2026-11-02, Barclays to $591 and Citi to $580 on 2026-10-30, and RBC Capital to $568 on 2026-10-30.\n- **Lincare actions could lift margins.** Lincare has weighed on margins since the second quarter of 2026, as Lamba said on the 2026-07-31 call. A sale or restructuring would remove that drag. The company said fourth-quarter guidance assumes no meaningful profit improvement there.\n\n## Bear Case\n\n- **Growth slows in the guidance.** Fourth-quarter adjusted EPS guidance of $4.40–4.50 implies 5%–7% growth, against 9% in the third quarter, with no currency help assumed (2026-10-29 release).\n- **Gross margin has slid five quarters running.** Filed gross margin fell from 49.3% in the quarter to 2025-06-30 to 47.2% in the quarter to 2026-09-30. Reported operating margin was 22.9% in the latest quarter, against 27.5% in the June quarter, after the charge.\n- **Europe is barely growing.** Europe, Middle East and Africa underlying sales rose 3% in the third quarter, with volumes up only 1% (2026-10-29 release).\n- **The project pipeline has stopped expanding.** The sale-of-gas backlog stood at a record $8.1 billion after the 2026-07-31 second-quarter report, and $7.9 billion with the third-quarter report. The company expected it to end 2026 near $8 billion as more than 20 projects start up.\n- **Executives sold after option exercises.** SEC Form 4 filings show the chief financial officer sold 86,833 shares at an average of $521.21 on 2026-11-04 after exercising 228,175 options. The chief legal officer sold 9,350 shares at $518.91 on 2026-11-02.\n- **Not every target moved up.** BMO cut its target to $540 from $546 on 2026-11-03, and Equita's raised target of $520 on 2026-11-02 sits below the 2026-11-13 close.\n\n## Setup & Price Structure\n\nLinde closed at $526.06 on 2026-11-13. The 52-week intraday high is $548.20, set on 2026-07-07, and the last close is 4.0% below it. The 52-week closing low is $389.38, set on 2025-12-08.\n\nThe shares sit above both the 50-day moving average of $490.2 and the 200-day moving average of $494.57, as of the 2026-11-13 close. The 50-day average is still below the 200-day, so the recovery from late summer is recent. The three-month change is 11.3%, measured from a close of $474.33 on 2026-08-17.\n\nIn the week after the report the shares held a narrow range. They closed at $515.25 on 2026-11-06 and between $520.33 and $526.55 from 2026-11-09 to 2026-11-13. The July high is the level the price has to clear to show leadership.\n\n## Catalyst Calendar\n\n- **~2026-12-01 (est.):** ISM manufacturing index for November 2026. US factory activity drives Americas gas volumes, which rose only 3% in the third quarter; a sharp change would move expectations for 2027 volume growth.\n- **~2027-02-05 (est.):** Fourth-quarter 2026 report and 2027 outlook. It shows whether adjusted EPS lands in the $4.40–4.50 guide and whether 2027 guidance holds growth near the 8%–9% of 2026. It may also update the Lincare review.\n\n## What Would Change Our Mind\n\nA daily close above $549, which would put the shares above their July 2026 52-week high and show them leading, or a 2027 adjusted EPS outlook above the 8%–9% growth guided for 2026.\n\n## Correlation Notes\n\nLinde's results depend on industrial production in the Americas, Europe and Asia, on electronics demand, and on pricing in long-term gas contracts. Its closest US-listed peer is Air Products (APD). AdaptHealth (AHCO) competes with Lincare in US home respiratory care. A common market view is that large, low-volatility industrial-gas stocks trade as defensive holdings, so they hold up in index sell-offs and trail in strong rallies. The company issued two euro bond tranches of €650 million each on 2026-11-12, against debt of $26,702 million at 2026-09-30. That adds to its exposure to European rates and the euro, which the company assumed gave a 2% currency benefit to full-year 2026 EPS.",
  "first_seen": "2026-11-12",
  "last_analyzed": "2026-11-14T08:09:40+00:00",
  "last_synthesized": "2026-11-14",
  "date_modified": "2026-11-16",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}